Latest filing published 19 Dec 2023 for 이지바이오.
이지홀딩스: trading record in brief
이지홀딩스 is a declared insider of 이지바이오, with filings sourced from DART (FSS). Over a trading history stretching from 23 March 2021 to 14 December 2023, the count stands at 16 filings.
Every open-market trade on record is a purchase: 7 purchases worth €126k, and no sale. No amount is published for 6 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 3 purchases and no sales on the market.
The newest entry dates from 19 December 2023: an open-market purchase, in 이지바이오. Filings reach the DART (FSS) feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to 이지홀딩스
Open company profiles for insider transactions, fundamentals and analyst consensus when available.